Boost therapy of hepatocellular carcinoma by amplifying vicious cycle between mitochondrial oxidative stress and endoplasmic reticulum stress via biodegradable ultrasmall nanoparticles and old drug

氧化应激 内质网 线粒体 化学 药品 癌症研究 肝细胞癌 细胞生物学 纳米颗粒 压力(语言学) 药理学 生物物理学 纳米技术 医学 材料科学 生物化学 生物 哲学 语言学
作者
Hao Zhang,Li Wang,Hanghang Liu,Yaobao Han,Qing Yin Zheng,Qi Xu,Bolin Bao,Wei Xing,Zhen Li
出处
期刊:Nano Today [Elsevier]
卷期号:46: 101601-101601 被引量:17
标识
DOI:10.1016/j.nantod.2022.101601
摘要

Despite advances in early diagnosis and treatment of hepatocellular carcinoma (HCC), HCC shows a very high mortality and development of innovative drugs and treatment methods are highly desirable. Herein, we report an innovative therapy of HCC through the formation and amplification of vicious cycle between mitochondrial oxidative stress and ER stress by joint use of biodegradable ultrasmall Cu 2- x Se nanoparticles (CS NPs) and alcohol-abuse drug disulfiram (DSF). The CS NPs can alleviate the tumor hypoxia and generate reactive oxygen species (ROS) through their Fenton-like reaction with endogenous H 2 O 2 in tumor. Their released copper ions can react with DSF to in situ form active drug CuET to significantly suppress the growth of HCC and exhibit excellent anti-tumor effect. We reveal the novel anti-tumor mechanism of the formed CuET complex, which can immobilize nuclear protein localization protein 4 (NPL4) to inhibit the proteasome system to induce endoplasmic reticulum (ER) stress and increase the burden of Ca 2+ ions in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. The mitochondrial oxidative stress produces less ATP to induce the occurrence of autophagy, and the generated ROS further strengthens the ER stress. The formation of such vicious cycle between mitochondrial oxidative stress and ER stress significantly enhances the severe apoptosis of tumor cells and notable decrease in tumor size, which has been demonstrated in both subcutaneous and orthotopic HCC models. Our work provides insights into repurposing of metabolic nanoparticles and old drugs for new applications, demonstrates the great potential of this strategy in anti-tumor therapy. • Joint use of Cu2-xSe NPs and disulfiram can suppress HCC growth due to the in situ formation of anti-tumor drug CuET. • The CuET can cause and amplify a vicious cycle between ER stress and mitochondrial oxidative stress. • The ER stress increases the burden of Ca2+ in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. • The mitochondrial damage produces less ATP to induce autophagy, and the burst of ROS further strengthens the ER stress.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
隐形曼青应助小月采纳,获得10
1秒前
woobinhua发布了新的文献求助10
2秒前
hhxx发布了新的文献求助10
3秒前
欣慰外绣发布了新的文献求助10
3秒前
3秒前
3秒前
海藻发布了新的文献求助10
4秒前
4秒前
cuicui发布了新的文献求助20
5秒前
花花发布了新的文献求助10
5秒前
Jasper应助狠毒的小龙虾采纳,获得10
5秒前
qinzx完成签到,获得积分10
6秒前
科研通AI2S应助立方糖采纳,获得10
7秒前
hahaha完成签到,获得积分10
7秒前
8秒前
勤恳友灵发布了新的文献求助30
8秒前
wei发布了新的文献求助10
9秒前
caohai完成签到,获得积分10
9秒前
kk完成签到,获得积分10
9秒前
……发布了新的文献求助30
10秒前
11秒前
11秒前
暗能量发布了新的文献求助10
12秒前
13秒前
小韩完成签到 ,获得积分10
13秒前
14秒前
15秒前
整齐靖儿完成签到,获得积分20
15秒前
千千完成签到,获得积分10
15秒前
李爱国应助123采纳,获得10
16秒前
无限的山水完成签到,获得积分10
16秒前
小月发布了新的文献求助10
16秒前
gg2关注了科研通微信公众号
17秒前
17秒前
17秒前
cqsuper完成签到,获得积分10
17秒前
一一应助Ru采纳,获得20
18秒前
思源应助宋小姐冲鸭采纳,获得10
18秒前
19秒前
高分求助中
The Data Economy: Tools and Applications 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 800
Essentials of thematic analysis 700
A Dissection Guide & Atlas to the Rabbit 600
Внешняя политика КНР: о сущности внешнеполитического курса современного китайского руководства 500
Academia de Coimbra: 1537-1990: história, praxe, boémia e estudo, partidas e piadas, organismos académicos 500
Revolution und Konterrevolution in China [by A. Losowsky] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3120530
求助须知:如何正确求助?哪些是违规求助? 2771150
关于积分的说明 7706625
捐赠科研通 2426370
什么是DOI,文献DOI怎么找? 1288511
科研通“疑难数据库(出版商)”最低求助积分说明 621036
版权声明 600069